Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy

Authors:

Abstract
Hepatocellular carcinoma (HCC), the dominant form of primary liver cancer, is the third cause of cancer-related death worldwide.1 Immune checkpoint inhibitors (ICI) are used for the first-line trea...
Funding Information
  • Departamento de Salud, Gobierno de Navarra (045-2017)
  • Gobierno de Navarra (AGATA Project (0011-1411-2020-000010))
  • Instituto de Salud Carlos III (PI20/00260)
  • AC Grants
  • Fundación Intheos

This publication has 35 references indexed in Scilit: